Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Cash from Operations: 2009-2024

Historic Cash from Operations for Sunshine Biopharma (SBFM) over the last 16 years, with Dec 2024 value amounting to -$12.5 million.

  • Sunshine Biopharma's Cash from Operations rose 46.35% to -$727,800 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 million, marking a year-over-year increase of 39.65%. This contributed to the annual value of -$12.5 million for FY2024, which is 42.80% down from last year.
  • As of FY2024, Sunshine Biopharma's Cash from Operations stood at -$12.5 million, which was down 42.80% from -$8.8 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Cash from Operations ranged from a high of -$657,299 in FY2020 and a low of -$12.5 million during FY2024.
  • In the last 3 years, Sunshine Biopharma's Cash from Operations had a median value of -$8.8 million in 2023 and averaged -$8.9 million.
  • Data for Sunshine Biopharma's Cash from Operations shows a maximum YoY tumbled of 186.93% (in 2022) over the last 5 years.
  • Over the past 5 years, Sunshine Biopharma's Cash from Operations (Yearly) stood at -$657,299 in 2020, then tumbled by 178.28% to -$1.8 million in 2021, then slumped by 186.93% to -$5.2 million in 2022, then tumbled by 67.20% to -$8.8 million in 2023, then tumbled by 42.80% to -$12.5 million in 2024.